Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement last month criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.
Increasing access to birth control through the pharmacy may pose a challenge - will pharmacists who counsel patients on family planning be reimbursed for their efforts?
The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.
A collection of eight consumer groups have written to Federal Trade Commission chair Edith Ramirez in opposition of the ongoing potential merger between pharmaceutical companies Teva and Mylan.
Almost half of all people in an employer wellness program and with a chronic condition learned of their health status through that wellness program.
As many as 84% of Americans want the full array of cough, cold and allergy remedies in the drug store aisles even if they aren't sick at the time.
Both Mylan and Dr. Reddy’s Laboratories have announced the launch of their generic version of dementia drug Namenda.
The Food and Drug Administration warns patients that prolonged use of NSAIDs could increase risk of heart attack or stroke.
The White House has nominated Andy Slavitt, an advocate of data-driven health innovation, to serve as the Centers for Medicare and Medicaid Services’ administrator.
The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says.